Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway

Myocardial fibrosis (MF) is an important pathological change in diabetic cardiomyopathy. The aim of the present study was to investigate whether irbesartan serves a role in improving MF in a diabetic rat model. Fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high-density lipo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Min, Zhao, Hua, Li, Qiang, Li, Yanbing, Zhang, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523283/
https://www.ncbi.nlm.nih.gov/pubmed/33005243
http://dx.doi.org/10.3892/etm.2020.9245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523283/
https://www.ncbi.nlm.nih.gov/pubmed/33005243
http://dx.doi.org/10.3892/etm.2020.9245

Ejemplares similares